AVITA Medical Files 8-K on Financials
Ticker: AVHHL · Form: 8-K · Filed: Apr 11, 2024 · CIK: 1762303
| Field | Detail |
|---|---|
| Company | Avita Medical, Inc. (AVHHL) |
| Form Type | 8-K |
| Filed Date | Apr 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
AVITA Medical dropped an 8-K on April 10th detailing their financials. Check it out.
AI Summary
AVITA Medical, Inc. filed an 8-K on April 10, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Valencia, California.
Why It Matters
This 8-K filing provides crucial updates on AVITA Medical's financial performance and operational status, which is important for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant negative news.
Key Players & Entities
- AVITA Medical, Inc. (company) — Registrant
- April 10, 2024 (date) — Date of earliest event reported
- Valencia, California (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on AVITA Medical, Inc.'s Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on April 10, 2024.
Where are AVITA Medical, Inc.'s principal executive offices located?
AVITA Medical, Inc.'s principal executive offices are located at 28159 Avenue Stanford, Suite 220, Valencia, California, 91355.
What is AVITA Medical, Inc.'s state of incorporation?
AVITA Medical, Inc. is incorporated in Delaware.
What is the SEC file number for AVITA Medical, Inc.?
The SEC file number for AVITA Medical, Inc. is 001-39059.
Filing Stats: 474 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-04-11 17:05:38
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share RCEL The Nasdaq Stock Mar
Filing Documents
- rcel-20240410.htm (8-K) — 38KB
- rcel-ex99_1.htm (EX-99.1) — 16KB
- img262816717_0.jpg (GRAPHIC) — 20KB
- img262816717_1.jpg (GRAPHIC) — 20KB
- 0000950170-24-043776.txt ( ) — 231KB
- rcel-20240410.xsd (EX-101.SCH) — 26KB
- rcel-20240410_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On April 10, 2024, AVITA Medical, Inc. issued a press release announcing an update to its expected first quarter 2024 revenue. A copy of the press release is attached hereto as Exhibit 99.1. The information under this Item 2.02 and Exhibit 99.1 is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933 except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. 99.1 AVITA Medical Updates Expected First Quarter 2024 Revenue 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVITA Medical, Inc. Date: April 11, 2024 By: /s/ Donna Shiroma Donna Shiroma General Counsel